This project has been co-founded by the European Regional Developing Fund (ERDF), Thematic Objective 1, which pretends to promote technological development, innovation and quality research, and Junta de Castilla y León through the Instituto para la Competitividad Empresarial (ICE).

This research project is addressed to test molecules against COVID 19 and other viral agents.

Grant expedient number: 14/21/LE/0005

Completion period: 28 December 2022

This project has been granted to Neural Therapies SL by the European Regional Developping Fund (ERDF) from European Union and Junta de Castilla y León through the Instituto para la Competitividad Empresarial (ICE).

This research project is developping technology for the design and purification of exosomes. These microvesicles will be loaded with specific microRNAs to explore they potential use as antiinflamatory agents.

Grant expedient number: 04/18/LE/0009

Completion period: 28 February 2021